SUMMARY When day-old ducklings susceptible to duck virus hepatitis (DVH) were inoculated with a DVH classic modified-live-virus (DVH-C-MLV) vaccine (1960 isolate) on a Long Island duck farm in 5 subsequent hatches and then exposed almost simultaneously to pathogenic field virus, average mortality was 33%, while the range of hatch mortality was 11 to 76%. Ducks started to die 4 days after hatching. Peak mortality was on the 6th day in 1 hatch and on the 8th day in the 4 other hatches. From the 9th to 12th day there was a limited mortality, with no losses thereafter in any hatch. Groups of 3 hatches of ducklings of the Duck Research Laboratory (DRL), susceptible to DVH, were inoculated with the monovalent DVH-C-MLV vaccine, a monovalent DVH-variant-MLV (DVH-V-MLV) vaccine (1970 isolate), or a bivalent DVH-CVMLV vaccine. The inoculated groups and their unvaccinated hatchmates were exposed to field virus on the above-mentioned farm 5, 6, and 8 days after vaccination. Average mortalities of the 3 hatches were: unvaccinated controls, 65% (range 34 to 81%o); DVH-V-MLV inoculated groups, 57% (44 to 66%); DVH-CV-MLV inoculated groups, 29% (18 to 46%); and the DVH-C-MLV-inoculated ducks, 24% (10 to 46%). Eight days were not enough to develop a complete protection in ducklings inoculated by any of the tested vaccines. Although the